| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 670,400 | 724,900 | 686,000 | 638,800 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 724,900 | 686,000 | 638,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 242,900 | 632,800 | 593,000 | 718,200 | | Non Recurring |
-
|
-
|
-
| (47,500) | | Others |
-
| 31,200 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 70,500 | 60,900 | 93,000 | (31,900) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 99,900 | 60,900 | 93,000 | (31,900) | | Interest Expense | 9,700 | (24,200) | 43,900 | (68,100) | | Income Before Tax | 90,200 | 85,100 | 49,100 | 36,200 | | Income Tax Expense | 30,300 | 28,800 | 16,400 | 12,200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 59,900 | 56,300 | 32,700 | 24,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 59,900 | 56,300 | 32,700 | 24,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $59,900 | $56,300 | $32,700 | $24,000 |
|
1.29% Nasdaq 
Income Statement
